1New pharmacological tools:the use of diterpenes to promote adult hippocampal neurogenesisRicardo Gómez-Oliva, Pedro Nunez-Abades, Carmen Castro1629-16302Clustering of voltage-gated ion channels as an evolutionary trigger of myelin formationHenrike Ohm, Simone Rey, Christian Klämbt1631-16323Using microglia-derived extracellular vesicles to capture diversity of microglial activation phenotypes following neurological injuryAustyn D.Roseborough, Nikita Ollen-Bittle, Shawn N.Whitehead1633-16344Sexual dimorphism of G protein-coupled receptor signaling in the brainSara Aljoudi, Hamdan Hamdan, Khaled S.Abd-Elrahman1635-16365Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucomaPete A.Williams, Robert J.Casson1637-16386MAP4K inhibition as a potential therapy for amyotrophic lateral sclerosisShuaipeng Ma, Chun-Li Zhang1639-16407Role of fullerenols derivative 3HFWC in the treatment of Alzheimer's diseaseSanja Ivkovic, Djuro Koruga1641-16428Monomeric C-reactive protein:a link between chronic inflammation and neurodegeneration?Nicoleta Arnaut, Ylenia Pastorello, Mark Slevin1643-16449Alterations of protein homeostasis in Alzheimer's disease:beyond Procrustean bed of endoplasmic reticulum stress and unfolded protein responseDmitry Lim, Alexei Verkhratsky1645-164610The big data challenge-and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyondSven Marcel Stefan, Muhammad Rafehi1647-164811p38-MAPK and CDK5,signaling pathways in neuroinflammation:a potential therapeutic intervention in Alzheimer's disease?Vlad Ionut Viorel, Ylenia Pastorello, Nosherwan Bajwa, Mark Slevin1649-165012Modifying the progression of Parkinson's disease through movement interventions:multimodal quantification of underlying mechanismsManuel Bange, Damian Marc Herz, Dumitru Ciolac, Gabriel Gonzalez-Escamilla, Sergiu Groppa1651-165213Targeting muscle to treat Charcot-Marie-Tooth diseaseDavid Villarroel-Campos, James N.Sleigh1653-165414Suppression of mature TAU isoforms prevents Alzheimer's disease-like amyloid-beta oligomer-induced spine loss in rodent neuronsSarah Buchholz, Hans Zempel1655-165715Small molecular decoys in Alzheimer's diseaseSho Oasa, Valentina L.Kouznetsova, Igor F.Tsigelny, Lars Terenius1658-165916Crosstalk among mitophagy,pyroptosis,ferroptosis,and necroptosis in central nervous system injuriesLi Zhang, Zhigang Hu, Zhenxing Li, Yixing Lin1660-167017Glucagon-like peptide 1 receptor activation:anti-inflammatory effects in the brainYolanda Diz-Chaves, Zainab Maastor, Carlos Spuch, José Antonio Lamas, Lucas C.González-Matías, Federico Mallo1671-167718Resident immune responses to spinal cord injury:role of astrocytes and microgliaSydney Brockie, Cindy Zhou, Michael G.Fehlings1678-168519Use of donepezil for neurocognitive recovery after brain injury in adult and pediatric populations:a scoping reviewAvery L.Miller, Nathan K.Evanson, J.Michael Taylor1686-169520The role of snapin in regulation of brain homeostasisJiawen Li, Xinqi Huang, Yumei An, Xueshi Chen, Yiyang Chen, Mingyuan Xu, Haiyan Shan, Mingyang Zhang1696-1701 